Medprin Regenerative Medical Technologies Co., Ltd. Stock
Equities
301033
CNE100004NB8
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
41 CNY | -0.61% | -5.14% | -5.83% |
Sales 2024 * | 288M 39.76M | Sales 2025 * | 377M 52.01M | Capitalization | 2.71B 374M |
---|---|---|---|---|---|
Net income 2024 * | 67M 9.25M | Net income 2025 * | 105M 14.49M | EV / Sales 2024 * | 9.4 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 7.19 x |
P/E ratio 2024 * |
39.8
x | P/E ratio 2025 * |
25.8
x | Employees | 278 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 38.47% |
1 day | -0.61% | ||
1 week | -5.14% | ||
Current month | +18.84% | ||
1 month | +17.71% | ||
3 months | +23.20% | ||
6 months | -6.61% | ||
Current year | -5.83% |
Managers | Title | Age | Since |
---|---|---|---|
Yu Yu Yuan
CEO | Chief Executive Officer | 44 | 08-08-31 |
Ya Hong Luo
DFI | Director of Finance/CFO | 56 | 17-01-31 |
Kun Xue Deng
CTO | Chief Tech/Sci/R&D Officer | - | 11-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Xin Lu
BRD | Director/Board Member | 61 | 18-10-31 |
Yu Yu Yuan
CEO | Chief Executive Officer | 44 | 08-08-31 |
Ya Hong Luo
DFI | Director of Finance/CFO | 56 | 17-01-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 41 | -0.61% | 507,500 |
24-05-27 | 41.25 | +2.59% | 705,100 |
24-05-24 | 40.21 | -2.71% | 860,476 |
24-05-23 | 41.33 | -0.89% | 796,532 |
24-05-22 | 41.7 | -0.81% | 1,087,885 |
End-of-day quote Shenzhen S.E., May 27, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.83% | 376M | |
+13.31% | 128B | |
-9.13% | 10.9B | |
-2.59% | 8.69B | |
+37.50% | 5.48B | |
-22.36% | 4.72B | |
-11.25% | 2.76B | |
-14.85% | 2.05B | |
-13.29% | 1.93B | |
-28.75% | 1.67B |
- Stock Market
- Equities
- 301033 Stock